DMTC is calling for expressions of interest for Round 3 of its Medical Countermeasures Program. NOTE: The deadline for submission of EOIs has now passed. Further enquiries can be submitted by email
Posted by Harry Baxter on February 28th, 2018 Tagged: Countermeasures, CSIRO, defence technology, DST, innovation, research
The CEO of the DMTC, Dr Mark Hodge, appeared before the joint parliamentary inquiry into ‘The benefits and risks of a Bipartisan Australian Defence Agreement as a basis of planning for, and funding of, Australian Defence capability’ on 23 February. Dr Hodge’s opening statement to the committee is available here.
Posted by Harry Baxter on February 26th, 2018 Tagged: collaboration, defence technology, DMTC, research, technology
DMTC’s program to support Australian development of Medical Countermeasures is continuing to grow and gain traction.
DMTC’s Program Leader for Medical Countermeasures, Dr Felicia Pradera will be presenting at a series of interactive sessions across Australia. (more…)
Posted by Harry Baxter on February 7th, 2018 Tagged: collaboration, Countermeasures, DMTC, DST, industry, research
DMTC industry partner Anteo Diagnostics Ltd has notified the ASX of the successful completion of the first milestone in their DMTC project, with initial studies demonstrating high-detection sensitivity.
Anteo has partnered with Planet Innovation, Deakin University and DMTC to further the technology readiness of Planet Innovation’s (Nplex) low cost, high sensitivity point of care diagnostic system using breakthrough reader technology.
Anteo’s contribution and objectives in Milestone 1 were to successfully functionalise nanoparticles requiring integration with Planet Innovation’s reader. Anteo has successfully established, optimised and verified a model lateral flow system for the nominated target assay using Mix&Go.
Work on the next milestone is already underway and is scheduled to be completed by next quarter.
The DMTC Medical Countermeasures (MCM) program recognises the increasingly important need to create, in Australia, an integrated multidisciplinary network focused on MCM product development.
Anteo’s statement is available here.
Posted by Harry Baxter on April 21st, 2017 Tagged: DMTC, MCM, research